Our customers' Feedback
Search:
Perform search
Categories list

Generic Bicalutamide - Casodex

News
Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Casodex
Treating prostate cancer.Bicalutamide...
$4.65
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Medivation Files Enzalutamide NDA - Zacks.com

    Medivation Files Enzalutamide NDAZacks.

  • Medivation Reports First Quarter Financial Results and Provides Corporate Update - MarketWatch (press release)

    Medivation Reports First Quarter Financial Results and Provides Corporate UpdateMarketWatch (press release)Continued to enroll patients in the Phase 2 TERRAIN trial, which is comparing the effect of enzalutamide versus bicalutamide, the most commonly used anti-androgen, on progression-free survival in approximately 370 men with advanced prostate cancer who .

  • MDVN Misses; Focus on Enzalutamide - Zacks.com

    MDVN Misses; Focus on EnzalutamideZacks.

  • MDVN Misses; Focus on Enzalutamide - Analyst Blog - NASDAQ

    MDVN Misses; Focus on Enzalutamide - Analyst BlogNASDAQEnzalutamide is also in a phase II study (TERRAIN), which will compare enzalutamide with bicalutamide, in advanced prostate cancer patients who have progressed following medical castration with LHRH analog therapy or surgical castration.

  • New Therapies for Prostate Cancer: The Practicalities - OncLive

    OncLiveNew Therapies for Prostate Cancer: The PracticalitiesOncLive12,13 This investigational agent is an irreversible androgen receptor (AR) antagonist and AR signaling inhibitor, and represents an advance from the nonsteroidal AR antagonists flutamide, bicalutamide, and nilutamide.

    Copyright © 2005-2012 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy.
www.canadianpharmacyonline.biz is an affiliate marketing website